These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 809127)
21. [Neuronal circuits involved in the physiopathology of parkinsonian syndromes]. Poirier LJ; Bédard P; Langelier P; Larochelle L; Parent A; Roberge A Rev Neurol (Paris); 1972 Jul; 127(1):37-50. PubMed ID: 4203482 [No Abstract] [Full Text] [Related]
22. Influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced injury of dopaminergic nigrostriatal system on movement components of the instrumental reflex and motor thalamic neurons' reactions in the cat. Voloshin MYa ; Zelenskaya VS; Lukhanina EP; Burchinskaya LF; Kolomietz BP; Nosenko ND Neuroscience; 1991; 45(2):291-305. PubMed ID: 1762681 [TBL] [Abstract][Full Text] [Related]
23. Medical treatment of Parkinson disease. Stacy M Neurol Clin; 2009 Aug; 27(3):605-31, v. PubMed ID: 19555824 [TBL] [Abstract][Full Text] [Related]
24. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. Wichmann T; Bergman H; DeLong MR J Neurophysiol; 1994 Aug; 72(2):521-30. PubMed ID: 7983516 [TBL] [Abstract][Full Text] [Related]
25. [Parkinsonian tremor and the action of harmaline: experimental facts and hypothetical mechanisms]. Lamarre Y; Dumont M; Joffroy AJ Arch Ital Biol; 1973 Dec; 111(3-4):493-503. PubMed ID: 18847047 [No Abstract] [Full Text] [Related]
27. The role of striatal cholinergic mechanisms for the development of limb rigidity: an electromyographic study in rats. Schwarz M; Ikonomidou C; Klockgether T; Turski L; Ellenbroek B; Sontag KH Brain Res; 1986 May; 373(1-2):365-72. PubMed ID: 2872938 [TBL] [Abstract][Full Text] [Related]
28. [The characteristics of a parkinsonian syndrome induced in an experiment by a deficiency of nigrostriatal dopamine and by stimulation of the cholinergic neurons of the caudate nucleus]. Kryzhanovskiĭ GN; Atadzhanov MA; Voronina TA; Nerobkova LN Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(6):3-7. PubMed ID: 8160497 [TBL] [Abstract][Full Text] [Related]
29. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism. Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469 [TBL] [Abstract][Full Text] [Related]
30. Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease. Escande MV; Taravini IR; Zold CL; Belforte JE; Murer MG J Neurosci; 2016 May; 36(21):5686-98. PubMed ID: 27225760 [TBL] [Abstract][Full Text] [Related]
31. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model. Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409 [TBL] [Abstract][Full Text] [Related]
32. Disappearance of rhythmic involuntary movements during sleep in a case of olivopontocerebellar atrophy. Miyamoto M; Miyamoto T; Yokota N; Hirata K; Katayama S Psychiatry Clin Neurosci; 1999 Apr; 53(2):287-90. PubMed ID: 10459714 [TBL] [Abstract][Full Text] [Related]
33. Chapter 33: the history of movement disorders. Lanska DJ Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136 [TBL] [Abstract][Full Text] [Related]
34. Peduncular 'rubral' tremor and dopaminergic denervation: a PET study. Remy P; de Recondo A; Defer G; Loc'h C; Amarenco P; Planté-Bordeneuve V; Dao-Castellana MH; Bendriem B; Crouzel C; Clanet M Neurology; 1995 Mar; 45(3 Pt 1):472-7. PubMed ID: 7898699 [TBL] [Abstract][Full Text] [Related]
35. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism. Frohna PA; Rothblat DS; Joyce JN; Schneider JS Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343 [TBL] [Abstract][Full Text] [Related]
36. High-frequency stimulation of the subthalamic nucleus suppresses experimental resting tremor in the monkey. Gao DM; Benazzouz A; Piallat B; Bressand K; Ilinsky IA; Kultas-Ilinsky K; Benabid AL Neuroscience; 1999 Jan; 88(1):201-12. PubMed ID: 10051201 [TBL] [Abstract][Full Text] [Related]
37. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Burns RS; Chiueh CC; Markey SP; Ebert MH; Jacobowitz DM; Kopin IJ Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4546-50. PubMed ID: 6192438 [TBL] [Abstract][Full Text] [Related]
38. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease. Mavridis M; Degryse AD; Lategan AJ; Marien MR; Colpaert FC Neuroscience; 1991; 41(2-3):507-23. PubMed ID: 1870701 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological basis of akinesia in Parkinson's disease. Narabayashi H J Neural Transm Suppl; 1983; 19():143-51. PubMed ID: 6583305 [TBL] [Abstract][Full Text] [Related]
40. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Marsden CD; Obeso JA Brain; 1994 Aug; 117 ( Pt 4)():877-97. PubMed ID: 7922472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]